Gangliocytic paraganglioma: A case report
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Gangliocytic paragangliomas (GPs) are rare duodenal neuroendocrine tumors. Surgical resection is the primary treatment, with radiotherapy considered for lymph node invasion.
Area Of Science
- Gastroenterology
- Surgical Oncology
- Pathology
Background
- Paragangliomas (PGLs) are rare neuroendocrine tumors (NET) originating from the adrenal gland or extra-adrenal paraganglia.
- Extra-adrenal PGLs can develop a gangliocytic component, forming gangliocytic paragangliomas (GPs), most commonly in the duodenum.
Observation
- A 43-year-old patient presented with epigastric pain, nausea, and vomiting.
- CT scan revealed a duodenal nodular lesion.
- Ultrasound-guided Fine Needle Aspiration (FNA) showed neuroendocrine cells and neural tissue.
Findings
- Surgical resection was performed as the primary treatment for the duodenal gangliocytic paraganglioma.
- Adjuvant radiotherapy was not administered due to the absence of lymphatic or pancreatic parenchyma invasion.
Implications
- The management of GPs is not standardized and requires a multidisciplinary team approach.
- Surgical resection remains the cornerstone of GP treatment.
- Adjuvant radiotherapy may be considered in cases with confirmed lymph node invasion.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.